CN102947281B - 作为感觉器官和有丝分裂后组织的再生促进物质的新颖的氨基烷基噁唑甲酰胺和氨基烷基噻唑甲酰胺 - Google Patents

作为感觉器官和有丝分裂后组织的再生促进物质的新颖的氨基烷基噁唑甲酰胺和氨基烷基噻唑甲酰胺 Download PDF

Info

Publication number
CN102947281B
CN102947281B CN201180017156.5A CN201180017156A CN102947281B CN 102947281 B CN102947281 B CN 102947281B CN 201180017156 A CN201180017156 A CN 201180017156A CN 102947281 B CN102947281 B CN 102947281B
Authority
CN
China
Prior art keywords
cells
purposes according
cycloalkyl
cell
replace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180017156.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN102947281A (zh
Inventor
H.艾克霍夫
H.勒文海姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMC Microcollections GmbH
Original Assignee
EMC Microcollections GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMC Microcollections GmbH filed Critical EMC Microcollections GmbH
Publication of CN102947281A publication Critical patent/CN102947281A/zh
Application granted granted Critical
Publication of CN102947281B publication Critical patent/CN102947281B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201180017156.5A 2010-02-08 2011-02-04 作为感觉器官和有丝分裂后组织的再生促进物质的新颖的氨基烷基噁唑甲酰胺和氨基烷基噻唑甲酰胺 Expired - Fee Related CN102947281B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010007281A DE102010007281A1 (de) 2010-02-08 2010-02-08 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
DE102010007281.8 2010-02-08
PCT/EP2011/000502 WO2011095338A1 (de) 2010-02-08 2011-02-04 Neue aminoalkyl-oxazol- und aminoalkyl-thiazolcarbonsäureamide als regenerationsfördernde substanzen für sinnesorgane und postmitotische gewebe

Publications (2)

Publication Number Publication Date
CN102947281A CN102947281A (zh) 2013-02-27
CN102947281B true CN102947281B (zh) 2015-11-25

Family

ID=43754901

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180017156.5A Expired - Fee Related CN102947281B (zh) 2010-02-08 2011-02-04 作为感觉器官和有丝分裂后组织的再生促进物质的新颖的氨基烷基噁唑甲酰胺和氨基烷基噻唑甲酰胺

Country Status (7)

Country Link
US (2) US20130012514A1 (https=)
EP (1) EP2534139A1 (https=)
JP (1) JP2013518917A (https=)
CN (1) CN102947281B (https=)
CA (1) CA2789013A1 (https=)
DE (1) DE102010007281A1 (https=)
WO (1) WO2011095338A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2871181B1 (en) 2013-11-12 2016-10-05 Acousia Therapeutics GmbH Novel Compounds for Regeneration of Terminally-Differentiated Cells and tissues
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378803A (en) * 1987-12-11 1995-01-03 Sterling Winthrop Inc. Azole-fused peptides and processes for preparation thereof
CN1353605A (zh) * 1999-03-26 2002-06-12 欧洲凯尔特股份有限公司 芳基取代的吡唑、咪唑、噁唑、噻唑和吡咯及其应用
CN1906155A (zh) * 2003-12-03 2007-01-31 利奥制药有限公司 异羟肟酸酯衍生物及其医药用途
EP2009005A1 (en) * 2006-04-19 2008-12-31 Astellas Pharma Inc. Azolecarboxamide derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19807426A1 (de) * 1998-02-23 1999-10-14 Otogene Biotechnologische Fors Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
EP1126855B1 (en) * 1998-09-25 2007-05-09 Cephalon, Inc. Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
CN1441841B (zh) * 2000-07-11 2013-03-20 桑得医药品公司 对内耳的细胞再生和分化的刺激
JP2008502595A (ja) * 2004-03-31 2008-01-31 エグゼリクシス， インコーポレイテッド 未分化リンパ腫キナーゼモジュレータおよびその使用方法
GB0614538D0 (en) * 2006-07-21 2006-08-30 Univ Cambridge Tech Therapeutic Compounds And Their Use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378803A (en) * 1987-12-11 1995-01-03 Sterling Winthrop Inc. Azole-fused peptides and processes for preparation thereof
CN1353605A (zh) * 1999-03-26 2002-06-12 欧洲凯尔特股份有限公司 芳基取代的吡唑、咪唑、噁唑、噻唑和吡咯及其应用
CN1906155A (zh) * 2003-12-03 2007-01-31 利奥制药有限公司 异羟肟酸酯衍生物及其医药用途
EP2009005A1 (en) * 2006-04-19 2008-12-31 Astellas Pharma Inc. Azolecarboxamide derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
2011800171565;邹雯;《STN检索报告》;20140211 *

Also Published As

Publication number Publication date
US8889723B2 (en) 2014-11-18
CN102947281A (zh) 2013-02-27
CA2789013A1 (en) 2011-08-11
EP2534139A1 (de) 2012-12-19
DE102010007281A1 (de) 2011-08-11
WO2011095338A1 (de) 2011-08-11
US20140288135A1 (en) 2014-09-25
JP2013518917A (ja) 2013-05-23
US20130012514A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
CN105039258B (zh) 将非神经元细胞重编程为神经元样细胞的方法和组合物
CA2853364C (en) Nmda receptor modulators and uses thereof
US11247974B2 (en) Small molecules that enable cartilage rejuvenation
ES2978203T3 (es) Agente terapéutico para la pérdida auditiva neurosensorial
JP2022507404A (ja) 眼疾患治療用のペプチド及び医薬組成物
WO2019177313A1 (ko) 세포 투과능 및 근육 재생능을 가지는 이중 기능성 펩타이드 및 이의 용도
CN108431016A (zh) 核酸前体药物
CN116390723B (zh) 用于将生物素递送至线粒体的方法和组合物
CN102947281B (zh) 作为感觉器官和有丝分裂后组织的再生促进物质的新颖的氨基烷基噁唑甲酰胺和氨基烷基噻唑甲酰胺
CN105541765A (zh) 牛蒡苷元氨基酸酯类衍生物及其制备方法和用途
JP7542258B2 (ja) 細胞の機械的恒常性を破壊し、組織器官の再生と修復を促進する方法、およびその使用
US20150045395A1 (en) Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
CN103130705B (zh) 苯并五元不饱和杂环类化合物或其药用盐及其制备方法、药物组合物及其应用
TWI627280B (zh) 用於在活體外培養口腔黏膜上皮祖細胞以及口腔黏膜上皮細胞的方法
US9233926B2 (en) Compounds for stem cell differentiation
WO2013168807A1 (ja) 移植細胞懸濁液用の添加剤及び治療用組成物
TWI575069B (zh) A method for continuously maintaining the growth of motor neuron precursor cells and a pharmaceutical composition
RU2305683C2 (ru) Протеин из растения pilocarpus heterophyllus - антагонист действия человеческого рилизинг-фактора гормона роста (ghrh), применение протеина для получения лекарственного средства (варианты), лекарственное средство (варианты), фармацевтическая композиция для противодействия эффектам ghrh, моноклональное антитело и способ выделения протеина (варианты)
CN108715882A (zh) 通过有丝分裂阻滞诱导的细胞叠套结构模型及其制备方法
US20230142705A1 (en) Use of anti-aging glycopeptides for inhibition of immune rejection of a graft
WO2014042292A1 (ko) 단백질 인산화효소 c 활성화제를 포함하는 줄기세포 부착 촉진용 조성물 및 줄기세포의 부착 촉진 방법
TW202313090A (zh) 天麻素於預防或治療肌萎縮性脊髓側索硬化症的用途
ES2607752T3 (es) Compuestos nuevos para regeneración de células y tejidos terminalmente diferenciados
EP3466421B1 (en) Composition for the treatment of peripheral nerve disorders
US7390826B2 (en) Inhibitors of animal cell motility and growth

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20170204

CF01 Termination of patent right due to non-payment of annual fee